Seelos Therapeutics, Inc. (SEEL) financial statements (2021 and earlier)

Company profile

Business Address 300 PARK AVENUE
NEW YORK, NY 10017
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1046241121
Cash and cash equivalents1046241121
Restricted cash and investments    00 
Receivables   1110
Inventory, net of allowances, customer advances and progress billings   1000
Inventory   1000
Other undisclosed current assets1000110
Total current assets:1147461322
Noncurrent Assets
Property, plant and equipment 001111
Other noncurrent assets 000000
Total noncurrent assets: 001221
TOTAL ASSETS:1147581523
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3125672
Accounts payable100121 
Accrued liabilities2113352
Employee-related liabilities 01111 
Debt   7903
Deferred compensation liability     00
Derivative instruments and hedges, liabilities1     1
Accrued environmental loss contingencies     00
Disposal group, including discontinued operation 0     
Deferred revenue and credits0 002
Other undisclosed current liabilities7    (0)4
Total current liabilities:11121116712
Noncurrent Liabilities
Long-term debt and lease obligation     5 
Long-term debt, excluding current maturities     5 
Capital lease obligations    0 
Liabilities, other than long-term debt 011221
Deferred revenue and credits   1 
Deferred compensation liability, classified     00
Other liabilities 000000
Derivative instruments and hedges, liabilities  112  
Other undisclosed noncurrent liabilities0    (0) 
Total noncurrent liabilities:0011261
Total liabilities:111212181312
Stockholders' equity
Stockholders' equity attributable to parent(0)34(8)(10)211
Common stock0000000
Additional paid in capital56328320309299292279
Accumulated deficit(56)(325)(316)(316)(309)(290)(268)
Total stockholders' equity:(0)34(8)(10)211
TOTAL LIABILITIES AND EQUITY:1147581523

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues0 16593
Revenue, net16593
Net investment income0      
Cost of revenue
(Cost of Goods and Services Sold)
   (4)(1)(1)(3)
Gross profit:0 1248(0)
Operating expenses(30)(9)(11)(15)(25)(31)(17)
Other undisclosed operating loss  (1)    
Operating loss:(30)(9)(11)(13)(21)(23)(17)
Nonoperating income (expense)(22)(0)(1)6201
Investment income, nonoperating     10
Gain on contract termination     11
Other nonoperating income (expense) 00(0)(0)1(0)
Interest and debt expense(0) (0)(1)(1)(0) 
Loss from continuing operations before income taxes:(51)(9)(12)(8)(20)(23)(16)
Other undisclosed income from continuing operations     0 
Loss from continuing operations:(51)(9)(12)(8)(20)(22)(16)
Income (loss) from discontinued operations     1(1)
Net loss:(51)(9)(12)(8)(20)(22)(17)
Other undisclosed net income (loss) attributable to parent0(0)1211  
Net income (loss) available to common stockholders, diluted:(51)(9)0(7)(19)(22)(17)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(51)(9)(12)(8)(20)(22)(17)
Comprehensive loss, net of tax, attributable to parent:(51)(9)(12)(8)(20)(22)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: